JP Morgan Chase
AIM

JP Morgan Chase’s AIM ImmunoTech AIM Stock Holding History

JP Morgan Chase’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$15 – 7887
2025
Q1 		$15 Hold
1
– – ﹤0.01% 7163
2024
Q4 		$28 Hold
1
– – ﹤0.01% 7232
2024
Q3 		$37 Hold
1
– – ﹤0.01% 7167
2024
Q2 		$43 Hold
1
– – ﹤0.01% 7054
2024
Q1 		$51 Hold
1
– – ﹤0.01% 7037
2023
Q4 		$38 Hold
1
– – ﹤0.01% 7246
2023
Q3 		$27 Buy
+1
New +$62 ﹤0.01% 7112
2023
Q2 		– Hold
0
– – – 6859
2023
Q1 		– Hold
0
– – – 7578
2022
Q4 		– Hold
0
– – – 7423
2022
Q3 		– Hold
0
– – – 7216
2022
Q2 		– Hold
0
– – – 7269
2022
Q1 		– Sell
-26
Closed -$2.24K – 7378
2021
Q4 		$2K Hold
26
– – ﹤0.01% 6541
2021
Q3 		$5K Buy
26
+2
+8% +$404 ﹤0.01% 6263
2021
Q2 		$5K Buy
+24
New +$5.14K ﹤0.01% 6142
2021
Q1 		– Sell
-31
Closed -$7K – 6599
2020
Q4 		$5K Sell
31
-143
-82% -$28.6K ﹤0.01% 5458
2020
Q3 		$37K Buy
+174
New +$43.5K ﹤0.01% 5026
2020
Q2 		– Hold
0
– – – 5976
2020
Q1 		– Hold
0
– – – 6012
2019
Q1 		– Hold
0
– – – 6314
2018
Q4 		– Hold
0
– – – 6190

Other funds holding AIM

Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

JP Morgan Chase's AIM Position: Q2 2025 in Review

JP Morgan Chase sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 1 share — an estimated $15 sold.

JP Morgan Chase first reported a position in AIM in Q3 2020 and held it in 12 quarters. The position peaked at $37K in Q3 2020. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • JP Morgan Chase reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 1 AIM ImmunoTech share in Q2 2025, an estimated $15.
  • JP Morgan Chase first reported a position in AIM ImmunoTech in Q3 2020 and held it in 12 quarters.
  • JP Morgan Chase's AIM ImmunoTech position peaked at $37K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.